Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy

By Sauer Mark V   Kavic Suzanne M  

Reproductive BioMedicine Online, Vol. 12, Iss. 2, 2006-02 ,pp. : 153-162

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

The US FDA `Black Box' Warning for Topical Calcineurin Inhibitors: An Ongoing Controversy

By Ring Johannes  

Drug Safety, Vol. 31, Iss. 3, 2008-01 ,pp. : 185-198

Adis International

Access to resources Recommend Favorite

Treatment of US Crotalidae Bites: Comparisons of Serum and Globulin-Based Polyvalent and Antigen-Binding Fragment Antivenins

By Seger Donna   Kahn Stephen  

Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol. 24, Iss. 4, 2005-01 ,pp. : 217-227

Adis International

Access to resources Recommend Favorite

CNS drugs approved by the centralised European procedure: true innovation or dangerous stagnation?

By Barbui Corrado   Cipriani Andrea   Lintas Camilla   Bertelé Vittorio   Garattini Silvio  

Psychopharmacology, Vol. 190, Iss. 2, 2007-02 ,pp. : 265-268

Springer Publishing Company

Access to resources Recommend Favorite

The European Commission, the EMEA and the US FDA have affirmed their commitment to regulatory cooperation

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 564, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite